PROGESTERONE RETARD PHARLON 500 mg/2 ml, solution for injection IM in an ampoule 3 ampoules of 2 ml
Active ingredients: HYDROXYPROGESTÉRONE (CAPROATE D')
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection3 ampoules of 2 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROGESTERONE RETARD PHARLON 500 mg/2 ml, solution injectable IM en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 3 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- BAYER HEALTHCARE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 4 Apr 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63907395CIP73086597CIP133400930865972Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROXYPROGESTÉRONE (CAPROATE D')solution | 500,0 mg · une ampoule de 2 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.